Human β-herpesvirus interactions in solid organ transplant recipients

Journal of Infectious Diseases

Volumn 183, Issue 2, 2001, Pages 179-184

  Mendez, J C ^a   Dockrell, D H ^a   Espy, M J ^a   Smith, T F ^a   Wilson, J A ^a   Harmsen, W S ^a   Ilstrup, D ^a   Paya, C V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; LIVER TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; PROPHYLAXIS; SEROLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GANCICLOVIR; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 0035863361     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317929     Document Type: Article

References (38)

1. HBLV (or HHV-6) in human cell lines
2. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus
3. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders
4. The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution
5. Three new human herpesviruses (HHV6, 7, and 8)
6. +T cells
7. Human herpesvirus 6
8. Human herpesvirus 7
9. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation
10. Human herpesvirus-6 in transplantation: An emerging pathogen
11. Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity
12. Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient
13. Human herpesvirus 6 infections after bone marrow transplantation: Clinical and virologic manifestations
14. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: Does it have clinical significance?
15. Human herpesvirus-6 infection after liver transplantation
16. Cytomegalovirus disease in renal allograft recipients: Is human herpesvirus 7 a co-factor for disease progression?
17. Correlation between the detection of viral DNA by the polymerase chain reaction in peripheral blood leukocytes and serological responses to human herpesvirus 6, human herpesvirus 7, and cytomegalovirus in renal allograft recipients
18. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients
19. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection
20. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation
21. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease
22. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: Evidence of a marrow-suppressive role for HHV-6 in vivo
23. Human herpesvirus 6 infection in renal transplantation
24. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients
25. Human herpesvirus 6
26. Human herpesviruses at sixes, sevens, and more
27. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures
28. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: Suppression of interleukin-2 synthesis and cell proliferation
29. In vitro activation of human herpesviruses 6 and 7 from latency
30. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients
31. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation
32. Definitions of cytomegalovirus infection and disease
33. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation
34. Polymerase chain reaction detection of human cytomegalovirus in over 2000 blood specimens correlated with virus isolation and related to urinary virus excretion
35. A prospective study of human herpesvirus type 6 detected by polymerase chain reaction after liver transplantation
36. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus
37. Prophylaxis and treatment of cytomegalovirus infection after solid organ transplantation
38. The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir